top of page

Transform your Strategic Sourcing and outsourcing functions to deliver Competitive Advantage

LS-SACS (Life Sciences - Sourcing Advisory and Consultancy Services) is a unique firm that effectively combines deep life sciences functional domain, global operations and outsourcing experience WITH Management Consulting expertise across strategy, operational excellence, IT and digital transformation, program management and organizational change and communications.    
Our customized and collaborative approach will deliver
reduced time to market and cost of operations WHILE improving quality, productivity and customer satisfaction to your customers.  Our clients include small, medium and large life sciences clients. 

home page sourcing slide.jpg
home page transformation slide.jpg

Our Strategic Sourcing and outsourcing (SSO) services are designed to deliver sustainable global and regional partnerships, improved quality and compliance, reduced cycle times and YOY cost benefits for small, medium and large life sciences clients. Services cover CRO, Functional Service Providers (FSP), BPO, and digital clinical trial technologies.   Our engagement models fit both the short term tactical assistance needs as well as the design and program management of end to end strategic outsourcing initiatives of clients.

Our Management Consultancy Services cover Business and functional strategy, Hybrid and Decentralized Clinical Trials operations and technology services, Business operations and performance, People and organizational change, IT Strategy and Digital Transformation Services.  Core functional areas include Clinical Operations, Clinical Data Services, including biostatistics and programming, Pharmacovigilance,  Regulatory Operations and other areas and will ensure  improved quality, productivity, safety and patients' satisfaction, decreased cycle time and cost of operations.

Articles and Case Studies

Article:  How A Service Management Group (SMG) Can Solve Common Outsourcing Issues and deliver sponsors' clinical transformation objectives (April 2023)

A comprehensive end-to-end sourcing and outsourcing approach that is strategic in all its elements can allow life science companies to leverage best practices and realize their clinical transformation objectives. While a great deal of focus is placed on the request for proposal (RFP) process, pricing, and contract negotiations, one of the critical areas not getting enough attention is the design and development of an internal, dedicated Service Management Group (SMG) that is adequately staffed, trained, and empowered to manage the multiple suppliers and the strategic objectives of the outsourcing programs. The size and shape of the SMG depends on the size of the company or the functions that are being serviced by the group, the number of outsourced suppliers, and the strategic nature of the relationships.

SMG slide.jpg

Case Study:  R&D Strategic sourcing and procurement advisory for a US Pharma (April 2023)

The R&D group within a US pharmaceutical company that was recently spun-off from a major Pharma, was establishing their procurement operations and rolling out multiple RFPs across CROs and Functional Service Providers (FSPs).   Pharma company’s approach included not only the identification of the most optimal supplier universe for clinical operations, regulatory services, pharmacovigilance and safety services, but also had several gaps in their approach on the RFP process, pricing approach, contracts structure and SLA / KPIs. 


LS-SACS provided assistance across multiple areas in the sourcing lifecycle – strategy, RFP response reviews, contract reviews and post contracting service management:

  • Reviewed the RFPs sent out to both global CRO and FSP vendors along with the MSA, pricing and other templates and identified “gaps” Vs best practices.  Areas included Term of contract, creation of separate SLA and KPI sections,

  • Redesigned the MSAs and Exhibit sections to ensure content, terms and SLA / KPIs reflected services in scope – full service clinical trials across Phases I-IV, regulatory operations and services and pharmacovigilance / drug safety services

  • Collaborated with leaders from clinical operations, quality, regulatory and medical writing, procurement, legal and finance to develop SLA section that included Service Level credits to cover critical metrics such as patient recruitment, active sites, quality, cycle times, and cost.

  • Developed a detailed “milestone-payment” approach to align CROs payments with the promised units / deliverables / outcomes within timelines, quality, cost. 

  • Recommended best practices approaches for pricing negotiations to include continuous improvement, transformation and YOY pricing reductions

  • Provided the best practices approach to re-design supplier management to align with best practices of “Service Management Groups”

Article:  Best Practices in Utilizing the FSP model: Clinical Operations, Pharmacovigilance, Regulatory and Other Areas, Applied Clinical Trials, November 16, 2021

The COVID-19 pandemic has shown that there’s a lot more flexibility in clinical trial systems than what was realized in the past. It has been a catalyst in speeding the digital process, making virtual trial conduct becoming a reality. To continue the momentum, life sciences companies need to have a dependable set of global and regional external partnerships that are flexible and scalable. These partnership models (e.g., CROs and FSPs) need to fit the diverse needs of small, medium, and large companies and a variety of “future-ready” operating models that can span clinical operations and associated functions (e.g., Clinical Data Services, PV, regulatory).  The engagement model can be either FTE (cost of resource/hour) or unit/deliverables based (e.g., number of Case Report Forms (CRF), Tables, Listings, Figures (TLF), PV cases, and number of visits). In an environment where sponsors are challenged to manage their staffing capacity..., 

Article:  Best Practices For Sourcing & Outsourcing In Clinical Operations, Clinical Leader, Guest Column, October 21, 2021

The life sciences industry is in the throes of innovation and transformation.  Targeted therapeutic approaches for cancer and rare diseases and rapidly evolving genomics and molecular medicine approaches are translating into
precision medicines and individualized therapeutic protocols. Gene therapy and gene editing are beginning to transform the industry at a fundamental level.  Decentralized clinical trials (DCT) are aiding the transformation, facilitating a patient-centric approach, and leveraging a variety of digital technologies. Recent application of mRNA-based platforms and expeditious trials and submissions have led to the approval of highly effective vaccines for COVID-19.....

Article:  Best Practices to Ensure Sourcing and Outsourcing Are Strategic Levers for Competitive Advantage,, May 17, 2022

Companies have outsourced business process management/services and technology primarily as a cost-saving strategy over the past decade.  Increasingly, organizations have been leveraging their partners for operational improvements, such as automation and migration to cloud. The trend is further shifting as they plan to accelerate transformation projects and anticipate relying on service providers more heavily in the future. This approach is complementary to their strategy of building their internal capabilities across people, process, and technology for driving strategic innovation and transformation programs.  Sourcing and outsourcing can provide significant contributions to a pharmaceutical company’s competitive growth objectives, provided they are considered strategic and designed, and implemented from this perspective.

Case Study:  Sourcing strategy and RFP process for selecting digital clinical systems integrators and product vendors for a major pharma 

A major pharma company had developed a future clinical vision and wanted to identify the most optimal mix of systems integrators and digital clinical operations platform vendors to implement their strategy.  LS-SACS worked in collaboration with the client and a leading Third Party sourcing advisory and consulting firm, in identifying the vendors that had the capabilities and vision / plan to align with the client's future clinical vision.  We delivered the most optimal RFP design and structure, joint solution, contracting, negotiation and customized scoring.   



Life Sciences - Sourcing Advisory and Consultancy Services (LS-SACS)

Edison, New New Jersey, USA


bottom of page